PulseMedica has developed a proprietary real-time 3D imaging and laser targeting system for the non-invasive screening and treatment of vitreoretinal diseases, starting with symptomatic vitreous opacities. This technology addresses the significant unmet need for safe and effective treatment options for millions suffering from vision impairments caused by eye floaters.
Funding
$16.7M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
SVFounders
Product
Problem
Millions worldwide suffer from vitreoretinal diseases, including symptomatic vitreous opacities (eye floaters), which can cause vision impairments, anxiety, and reduced quality of life. Current treatment options are limited, often invasive, and lack the safety and efficacy needed for widespread use. There is a significant unmet need for a safe, effective, and non-invasive office-based solution for screening, diagnosing, and treating these conditions.
Solution
PulseMedica is developing a medical device platform for non-invasive, image-guided laser treatment of vitreoretinal diseases, starting with symptomatic vitreous opacities. The platform utilizes 3D computer vision, real-time tracking, and femtosecond laser technology to provide automated and precise treatment. This technology aims to offer a safer and more effective alternative to existing treatments, improving the quality of life for individuals affected by eye floaters and other vitreoretinal conditions. The platform is designed to be used in an office setting, providing a convenient solution for both patients and healthcare providers.
Target Audience
The primary target audience includes ophthalmologists and optometrists seeking a safe, effective, and non-invasive solution for treating vitreoretinal diseases, as well as patients suffering from symptomatic vitreous opacities and other related conditions.
Features
- High-resolution real-time 3D imaging for accurate visualization of vitreoretinal structures
- Enhanced laser accuracy and safety through real-time tracking and image guidance
- Automated treatment planning to optimize laser delivery and minimize potential side effects
- Femtosecond laser technology for precise and non-invasive tissue ablation
- Intended for office-based use, providing a convenient treatment option